Emergent BioSolutions | Lucro Bruto Sobre Vendas

Gross Profit On Sales Alterar Data
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amarin USD 42.5M 14.47M 2023-09
ANI Pharmaceuticals USD 78.23M 5.49M 2023-12
Exact Sciences USD 475.02M 15.21M 2023-12
Exelixis USD 453.15M 1M 2023-09
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Ironwood Pharmaceuticals USD 117.13M 13.38M 2021-12
Lonza CHF 1.11B 134M 2023-06
Merck USD 11.29B 441M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Myriad Genetics USD 135M 700K 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pacira USD 133.55M 9.38M 2023-12
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
United Therapeutics USD 543.7M 4.4M 2023-12



Emergent BioSolutions Lucro Bruto Sobre Vendas - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.